All News #Library
Rare Diseases
Three Factors to Make a Next-Gen eCOA Platform Work
23 May 2025 //
EXPRESSPHARMA
Patient Groups, Industry Seek Changes to Rare Disease Drug Guidance
04 Apr 2019 //
RAPS
Are Orphan Drugs Getting Too Much Attention By Payers And Policymakers?
26 Jun 2018 //
FORBES
Biosimilars in oncology: a €2billion opportunity for European healthcare
30 Oct 2017 //
PHARMAPHORUM

Market Place
Sourcing Support